Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Posted on 7 January 20207 January 2020 by Christine Laroche

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • January 2020

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • FDA Approves Saphnelo (anifrolumab) for Moderate to Severe Systemic Lupus Erythematosus
  • Uptravi (selexipag) Receives FDA Approval for Intravenous Use in Adult Patients with Pulmonary Arterial Hypertension (PAH)
  • GSK Announces FDA Approval for Nucala (mepolizumab) for use in Adults with Chronic Rhinosinusitis with Nasal Polyps
  • FDA Approves Expanded Botox (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

RSS Pharma Manufacturing News

  • Amgen to construct new drug substance manufacturing plant in North Carolina
  • Sanofi to acquire mRNA partner Translate Bio for $3.2bn
  • Ipsen, Exicure to co-develop therapies for neurodegenerative diseases

SFB-Pharma Info

  • About Us
  • Contact
  • Office

RSS White papers and Web seminars

  • New Ways to Collaborate While Preserving Privacy
Proudly powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok